Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.
复制标题
DOI:
10.1016/j.cyto.2008.07.004
复制
发表时间:
2008-10
期刊:
影响因子:
3.8
通讯作者:
Bartfai, T.
中科院分区:
文献类型:
--
作者:
Osborn, O.;Brownell, S. E.;Sanchez-Alavez, M.;Salomon, D.;Gram, H.;Bartfai, T.
The proinflammatory cytokine Interleukin 1 beta (IL-1β) is elevated in obese individuals and rodents and it is implicated in impaired insulin secretion, decreased cell proliferation and apoptosis of pancreatic beta cells. In this study we describe the therapeutic effects by an IL-1β antibody to improve glucose control in hyperglycemic mice with diet induced obesity. After 13wks of treatment the IL-1β antibody treated group showed reduced glycated hemoglobin (*P = 0.049), reduced serum levels of proinsulin (*P = 0.015), reduced levels of insulin and smaller islet size (*P = 1.65E-13) relative to the control antibody treated group. Neutralization of IL-1β also significantly reduced serum amyloid A (SAA) which is an indicator of inflammation-induced acute phase response (*P = 0.024). While there was no improvement of obesity, a significant improvement of glycemic control and of beta cell function is achieved by this pharmacological treatment which may slow/prevent disease progression in Type 2 Diabetes.
登录
查看更多内容
影响因子:
3.8
作者:
DELIKAT, SE;GALVANI, DW;ZUZEL, M
通讯作者:
ZUZEL, M
影响因子:
4
作者:
Borjesson, Andreas;Carlsson, Carina
通讯作者:
Carlsson, Carina
影响因子:
56.9
作者:
BUNN, HF;GABBAY, KH;GALLOP, PM
通讯作者:
GALLOP, PM
影响因子:
56.9
作者:
BENDTZEN, K;MANDRUPPOULSEN, T;SVENSON, M
通讯作者:
SVENSON, M
影响因子:
2.4
作者:
Alheim, K;Bartfai, T
通讯作者:
Bartfai, T